Williamson Timothy J, Brymwitt Whitney M, Gilliland Jaime, Carter-Bawa Lisa, Mao Jun J, Lynch Kathleen A, Emard Nicholas, Omachi Sarah, Jacobs Rocky L, Tefera Metasebiya Y, Reese McKenzie T, Ostroff Jamie S
Department of Psychological Science, Loyola Marymount University, Los Angeles, CA, USA.
Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Transl Behav Med. 2025 Jan 16;15(1). doi: 10.1093/tbm/ibae074.
Stigma is a pervasive and distressing problem experienced frequently by lung cancer patients, and there is a lack of psychosocial interventions that target the reduction of lung cancer stigma. Mindful self-compassion (MSC) is an empirically supported intervention demonstrated to increase self-compassion and reduce feelings of shame and distress in non-cancer populations. However, there are several anticipated challenges for delivering MSC to lung cancer patients, and modifications may be needed to improve acceptability, appropriateness, and feasibility.
To gather feedback from lung cancer patients, psycho-oncology researchers, expert MSC teachers, and oncology clinicians to identify themes supporting the adaptation of MSC to reduce lung cancer stigma.
We conducted a two-phase process of stakeholder focus groups with researchers and clinicians (n=12) and semi-structured interviews with lung cancer patients (n=14) with elevated stigma. Transcripts were analyzed using thematic content analysis.
Five themes were identified: (i) Patients expressed a desire for an intervention that bolstered self-compassion and addressed stigma; (ii) Intervention instructions were acceptable and understood clearly; (iii) Patients preferred intervention content to directly address lung cancer and stigma yet mentioned that doing so should be done with sensitivity; (iv) Ambivalence about delivering the intervention in person or remotely; (v) Acceptance for an intervention of 8-weeks (or longer) with 90-minute sessions and a group size of ≤ 15.
Findings informed the development of an adapted clinical protocol for MSC for lung cancer (MSC-LC), which can be pilot tested to determine implementation outcomes (e.g. acceptability, feasibility, efficacy).
耻辱感是肺癌患者经常经历的一个普遍且令人痛苦的问题,并且缺乏旨在减少肺癌耻辱感的心理社会干预措施。正念自我同情(MSC)是一种经实证支持的干预措施,已证明可提高非癌症人群的自我同情并减少羞耻感和痛苦感。然而,将MSC应用于肺癌患者存在一些预期的挑战,可能需要进行调整以提高其可接受性、适宜性和可行性。
收集肺癌患者、心理肿瘤学研究人员、专业MSC教师和肿瘤临床医生的反馈,以确定支持调整MSC以减少肺癌耻辱感的主题。
我们对研究人员和临床医生(n = 12)进行了两阶段的利益相关者焦点小组讨论,并对耻辱感较高的肺癌患者(n = 14)进行了半结构化访谈。使用主题内容分析法对访谈记录进行分析。
确定了五个主题:(i)患者表示希望有一种能增强自我同情并解决耻辱感的干预措施;(ii)干预说明是可接受的且易于理解;(iii)患者希望干预内容能直接解决肺癌和耻辱感问题,但同时提到这样做应保持敏感性;(iv)对于亲自提供干预还是远程提供干预存在矛盾心理;(v)接受为期8周(或更长时间)、每次90分钟、小组规模≤15人的干预措施。
研究结果为肺癌的正念自我同情(MSC-LC)适应性临床方案的制定提供了依据,该方案可进行试点测试以确定实施效果(如可接受性、可行性、有效性)。